Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

CytoDyn reports evidence of HIV suppression with PRO-140

July 16, 2015

McGill University patents anti-GD cancer vaccine

July 6, 2015

NIH grant supports GeoVax's clade C HIV vaccine development program

July 6, 2015

Gilead submits NDA for emtricitabine/rilpivirine/tenofovir alafenamide in HIV

July 2, 2015

MK-1439A enters two new phase III studies in HIV

July 2, 2015

CytoDyn starts first phase III trial of PRO-140 in HIV infection

June 10, 2015

Enrollment complete in Apios's phase I/II trial of bryostatin-1 in HIV infection

June 8, 2015

Cannabis Science and IGXBio to investigate combination of CS-TATI-1 and GenePro in HIV

June 2, 2015

EMA validates MAA for emtricitabine/tenofovir alafenamide fumarate for HIV

May 29, 2015

Johnson & Johnson expands policy to enhance access to darunavir

May 19, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...